共 141 条
- [1] Laurer MS(2013)The Randomized Registry Trial — the next disruptive technology in clinical research? N Engl J Med 369 1579-1581
- [2] D’Agostino RB(2015)Registry-based randomized clinical trials - a new clinical trial paradigm Nat Rev Cardiol 12 312-316
- [3] James S(2016)Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research? J Clin Epidemiol 80 16-24
- [4] Rao SV(2017)Registry-based pragmatic trials in heart failure: current experience and future directions Curr Heart Fail Rep 14 59-70
- [5] Granger CB(2006)Factors that can affect the external validity of randomised controlled trials PLoS Clin Trials 1 e9-93
- [6] Li G(2005)External validity of randomised controlled trials: “to whom do the results of this trial apply?” Lancet 365 82-94
- [7] Sajobi TT(2010)How to assess the external validity of therapeutic trials: A conceptual approach Int J Epidemiol 39 89-1085
- [8] Menon BK(2013)Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): An open-label, randomised phase 3 trial Lancet Oncol 14 1077-119
- [9] Korngut L(2016)2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 37 67-922
- [10] Lowerison M(2015)Register or electronic health records enriched randomized pragmatic trials: The future of clinical effectiveness and cost-effectiveness trials? Nord J Heal Econ 5 62-42